Continuing Education Credit

This conference offers Nursing Continuing Professional Develpment (NCPD) and continuing medical education (CME). Details to follow.

Registration

Registration Rates  
Type Early Bird Rate Regular Rate
ASTCT Member Rate $275 $350
Non-Member Rate $375 $450
Trainee Rate $225 $300

Register Today

Agenda

Please note, schedule is subject to change. Last update: June 30, 2026. View speaker disclosures.

Day 1: Thursday, October 22
8:00 – 8:15 AM Housekeeping
8:15 – 8:55 AM Keynote 
Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO; Translational Genomics Research Institute (TGen), City of Hope Cancer Center

9:00 – 9:40 AM

 Why Patients Miss CAR-T Trials: A Practical Framework for Identifying Eligible Candidates in Clinical Practice
Yan Leyfman, MD; New York Presbyterian Hospital
9:45 – 10:25 AM Quality and Safety in Transplant and Cellular Therapy: A Practical Approach to Improving Outcomes
Chris Dandoy, MD, MS; Cincinnati Children's Hospital Medical Center
10:30 – 10:45 AM Break
10:45 – 11:25 AM Cord Blood Transplantation in the Modern Era
Warren Fingrut, MD, MPH; MD Anderson

11:30 AM – 12:00 PM

 GI Toxicities and Nutrition during Allogeneic Stem Cell Transplant
Tracy Farrell, PA-C; University of Colorado Anschutz
Katie Harper, MS, RD, CNSC, CSO; UC Health
12:00 – 1:00 PM Lunch 
1:00 – 1:25 PM Post Transplant TA-TMA
Leonor Perez Aquino, DNP, ApRN-C, AOCNP, TCTCN; Miami Cancer Institute
1:30 – 2:15 PM Advanced Cellular Therapy for Cancer: CAR T beyond FDA Approval
Siddhartha Ganguly, MD, FACP; Houston Methodist Hospital Neal Cancer Center
2:15 – 2:30 PM Break
2:30 – 3:10 PM GVHD Prophylaxis in 2026 - PTCy, Dose Optimization, and Emerging Combination Strategies
Nihar Desai, MD, DM; Princess Margaret Cancer Center
3:15 – 3:55 PM

Transforming Therapies for Sickle Cell Disease
Anil George, MD; Baylor College of Medicine/Texas Children's Hospital
4:00 – 4:30 PM Ethical Issues Inherent in Caring for Stem Cell Transplantation and Cellular Therapy
Joyce Neumann, PhD, APRN, AOCN, HEC-C, FAAN; The University of Texas MD Anderson Cancer Center
Day 2: Friday, October 23
Track Beginner Adult Pediatric
8:00 – 8:45 AM Keynote: Best of TANDEM
Margy MacMillan, MD, MSc, FRCPC; University of Minnesota
8:45 – 9:25 AM Who Gets a Transplant? Disease, Patient and Donor Factors in Allo Transplant Candidacy
Charlotte Hughes, MD; Memorial Sloan Kettering Cancer Center		 Understanding and Comparing Eligibility for HSCT and CART for Elderly Patients (>70): The Role of Frailty, Functional Trajectories, and T Cell Fitness
Marco Ruiz, MD, MPH, MSc, MBA; Miami Cancer Institute/Florida International University		 Gene Therapy for WAS and SCID
Sung-Yun Pai, MD; National Cancer Institute
9:30 – 10:10 AM Conditioning Regimens
Boglarka Gyurkocza, MD; Fred Hutchinson Cancer Center		 Immunotherapies in Multiple Myeloma
Muhammad Faisal, MD; OU Health Stephenson Cancer Center		 Mixed Lineage Leukemia
Sara Silbert; National Cancer Institute
10:15 – 10:30 AM Break
10:30 – 11:10 AM Going Viral: A Timeline of Infection in Transplant
Leah Yoke, PA-C, MCHS; Fred Hutchinson Cancer Center		 Case Study Review: Infectious Diseases in Hematopoietic Stem Cell Transplant
Kristin Lind, APRN-CNP; The Ohio State University		 Post-Transplant Vaccinations
Paul Carpenter; Fred Hutchinson Cancer Center
11:15 – 11:55 AM Recognizing and Managing GVHD: A Practical Guide for Clinical Care
Doris Ponce, MD, MS; Memorial Sloan Kettering Cancer Center		 Beyond Steroids: Updates in Chronic Graft versus Host Disease
Brooke Adams, PharmD, BCOP; Orlando Health Cancer Institute		 GVHD in Children: Don't Throw Out the Tried and True: Integrating Established and Emerging Therapies
Vinita Pai, PharmD, MS, BCPPS; The Ohio State University, College of Pharmacy
12:00 – 1:00 PM Lunch 
1:00 – 1:25 PM CAR-T Toxicities Made Practical: A Case-Based Approach to CRS, ICANS, and Delayed Neurotoxicity
Basem William, MD, MRCP(UK), FACP; OhioHealth		 A Case of Relapsed/Refractory Diffuse Large B-cell Lymphoma: Impact of Prior CAR T-cell Therapy on Subsequent Treatment Lines
Grace Li, CRNP, AOCNP; National Cancer Institute		 TA-TMA Complicated Case Review
Samantha Newman, AC-PNP; University of Michigan
1:30 – 2:15 PM The Price of Cure: Transplant-Related Organ Toxicity in Hematopoietic Cell Transplantation
Sanja Zepcan, PharmD; Loyola University Medical Center		 Sexual Health in Adults with Cancer: Assessment, Monitoring, and Management for Healthcare Professionals
Daniel Verina, DNP, MSN, RN, ACNP-BC; Mount Sinai Medical Center		 Early Recognition and Management of Pediatric VOD/SOS After HCT: From Bedside Warning Signs to Defibrotide Decisions
Mayada Shanap, MD; King Hussein Cancer Center
2:15 – 2:30 PM Break
2:30 – 3:10 PM CAR‑ Decoded: Indications, Toxicities, and Real-World Practice
Gabriel Sanchez-Pettito, MD; Baylor College of Medicine		 Navigating Anti-BCMA CAR T Cell Therapy Toxicities: Recognition, Management, and Future Directions
Francesca Cottini, MD; The Ohio State University		 Pediatric CAR-T Coordination from Referral Through Follow-up
Anna Sparrow, PhD, MPH, RN; Children's Hospital of Philadelphia
3:15 – 3:55 PM HLA Matching in Transplant: What Every Clinician Needs to Know
Rajdeep Das, MD, PhD; University Hospitals Cleveland Medical Center		 Disease Evaluation and Transplant Strategies for Patients with Myelofibrosis
Rachel Salit, MD; Fred Hutchinson Cancer Center		 Microbiome (Full topic name TBD)
Robert Jenq, MD; City of Hope
4:00 – 4:30 PM A Practical Guide to Post-Transplant Maintenance Therapy
Olivia White, PharmD, BCOP; UT Southwestern Medical Center		 DLI: Past, Present, and Future
Emily Bauer, DNP, APRN, AGACNP-BC; University of Chicago Medicine		 Complex Social Situations 
Daniel Gaylor; Moffit